Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Biotron ( (AU:BIT) ) has provided an announcement.
Biotron Limited has successfully completed the acquisition of Sedarex Limited, a move approved by its shareholders. This acquisition involves the issuance of 500 million consideration shares and 33,333,333 facilitation shares, with certain shares subject to voluntary escrow, indicating strategic growth and potential expansion in Biotron’s operations.
More about Biotron
Biotron Limited operates in the biotechnology industry, focusing on the development of antiviral therapies. The company is primarily engaged in creating innovative treatments for viral infections, with a market focus on addressing unmet medical needs in this sector.
YTD Price Performance: -38.89%
Technical Sentiment Signal: Sell
Current Market Cap: A$4.98M
Find detailed analytics on BIT stock on TipRanks’ Stock Analysis page.